2013 Rare Neuroimmune Disorders Symposium
October 25-26, 2013 | Dallas, Texas
The STATE of the State of Rare Neuroimmune Diseases
Benjamin Greenberg, MD, MHS | University of Texas Southwestern Medical Center and Children’s Medical Center Dallas
SESSION I: REHABILITATIVE MEDICINE FOR RARE NEUROIMMUNE DISEASES
Goals of Rehabilitation: Restoration vs. Maintenance – Meet Us Halfway
Kathleen Zackowski, PhD, OTR | Kennedy Krieger Institute and Johns Hopkins University School of Medicine
Understanding Activity-Based Rehabilitation
Cristina Sadowsky, MD | Kennedy Krieger Institute and Johns Hopkins University School of Medicine
Functional Electrical Stimulation (FES): What We Have Learned
Daniel Becker, MD | International Neurorehabilitation Institute and Johns Hopkins University School of Medicine
Gait Training After Spinal Cord Injury
Karen McCain, DPT | University of Texas Southwestern Medical Center
Cognitive Rehabilitation in Rare Neuroimmune Diseases
Lana Harder, PhD | University of Texas Southwestern Medical Center and Children’s Medical Center Dallas
SESSION II: SURGICAL AND DEVICE BASED REHABILITATION STRATEGIES
Understanding Nerve Transfers
Jonathan Cheng, MD | University of Texas Southwestern Medical Center
Treatment Options for Refractory Neurogenic Bladder Conditions
Gary Lemack, MD | University of Texas Southwestern Medical Center
SESSION III: DRUG BASED FUNCTIONAL RECOVERY
Spinal Cord: From Biological Networks to Recovery
Carlos Pardo, MD | Johns Hopkins University School of Medicine
Spasticity Management
Donna Graves, MD | University of Texas Southwestern Medical Center
Ampyra or Dalfampridine and Gait Improvement
Michael Levy, MD, PhD | Johns Hopkins University School of Medicine
Q&A with panel discussion
Moderator: Teri Schreiner, MD, MPH | Children’s Hospital Colorado
Keynote Reception
Anjali Forber-Pratt, PhD | Paralympic Medalist and Faculty | University of Kansas
Recovering Vision After Optic Neuritis: Results of a 4-AP Study
Lindsay Horton, MD | University of Texas Southwestern Medical Center
Drugs and Cognition
Allen DeSena, MD | University of Texas Southwestern Medical Center
SESSION IV: DRUG-BASED REPAIR THERAPIES
What Drug Companies and the FDA Need from Us
Benjamin Greenberg, MD, MHS | University of Texas Southwestern Medical Center and Children’s Medical Center Dallas
Use of Anti-Lingo 1 for Remyelination in TM and NMO
Benjamin Greenberg, MD, MHS | University of Texas Southwestern Medical Center and Children’s Medical Center Dallas
rHigM22: A Novel Investigational Compound to Enhance Remyelination in the Central Nervous System
Anthony Caggiano, MD, PhD and Andrew Eisen, MD, PhD | Acorda Therapeutics, Inc.
SESSION V: CELL-BASED REPAIR STRATEGIES
Are We Ready For a Stem Cell Trial in Transverse Myelitis?
Michael Levy, MD, PhD | Johns Hopkins University School of Medicine
Neurotrophin Gene Therapy for Repair of the Injured Spinal Cord
George M. Smith, PhD | Shriners Hospitals Pediatric Research Center and Temple University
The Role of Mesenchymal Stem Cells in treatment of Transverse Myelitis
Barbara Krynska, MS, PhD | Shriners Hospitals Pediatric Research Center and Temple University
Q&A with panel discussion
